Cargando…
Towards a safety net for management of 22q11.2 deletion syndrome: guidelines for our times
The commonest autosomal deletion, 22q11.2 deletion syndrome (22q11DS) is a multisystem disorder varying greatly in severity and age of identification between affected individuals. Holistic care is best served by a multidisciplinary team, with an anticipatory approach. Priorities tend to change with...
Autores principales: | Habel, Alex, Herriot, Richard, Kumararatne, Dinakantha, Allgrove, Jeremy, Baker, Kate, Baxendale, Helen, Bu’Lock, Frances, Firth, Helen, Gennery, Andrew, Holland, Anthony, Illingworth, Claire, Mercer, Nigel, Pannebakker, Merel, Parry, Andrew, Roberts, Anne, Tsai-Goodman, Beverly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032642/ https://www.ncbi.nlm.nih.gov/pubmed/24384789 http://dx.doi.org/10.1007/s00431-013-2240-z |
Ejemplares similares
-
Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland
por: Edgar, John David M., et al.
Publicado: (2018) -
Improving the Health and Well‐Being of Adults With Conditions of a Genetic Origin: Views from Professionals, Syndrome Support Groups and Parents
por: Redley, Marcus, et al.
Publicado: (2016) -
1773. Complement level measurements for children in England suggest a possible unreported Post Streptococcal Glomerulonephritis Outbreak
por: Dale, Rachel, et al.
Publicado: (2023) -
Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency(1)
por: Ugrinovic, S., et al.
Publicado: (2020) -
Diminished seroconversion following a single SARS-COV-2 vaccine in
ocrelizumab-treated relapsing-remitting multiple sclerosis
patients
por: Georgieva, Zoya G, et al.
Publicado: (2021)